Stephens Consulting’s Qiagen QGEN Stock Holding History

Stephens Consulting’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-46	Closed	-$2.21K	–	975
2025 Q2	$2.21K	Buy	+46	New	+$2K	﹤0.01%	491

Other funds holding QGEN

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Stephens Consulting's QGEN Position: Q3 2025 in Review

Stephens Consulting sold out of Qiagen (QGEN) in Q3 2025, closing a stake of 46 shares — an estimated $2.21K sold.

Stephens Consulting first reported a position in QGEN in Q2 2025 and held it in 1 quarter. The position peaked at $2.21K in Q2 2025. 338 funds tracked by Wall St. Rank hold QGEN as of Q3 2025.

Stephens Consulting reported no remaining Qiagen position as of Q3 2025 after selling out during the quarter.
Stephens Consulting sold 46 Qiagen shares in Q3 2025, an estimated $2.21K.
Stephens Consulting first reported a position in Qiagen in Q2 2025 and held it in 1 quarter.
Stephens Consulting's Qiagen position peaked at $2.21K in Q2 2025.
338 funds tracked by Wall St. Rank held Qiagen as of Q3 2025.

Based on Stephens Consulting's 13F filing for Q3 2025, filed 15 Oct 2025.